Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucerastat in Fabry Disease
NCT03425539Phase 3Completed
- Sponsor
- Idorsia
- Start
- Jun 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of lucerastat in Fabry disease (FD), sponsored by Idorsia. Started Jun 2018; status: completed.
02
Drugs
lucerastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT03425539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425539.